10959693

Source:http://linkedlifedata.com/resource/pubmed/id/10959693

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0164707, umls-concept:C0332307, umls-concept:C0441655, umls-concept:C2587213
pubmed:issue	2
pubmed:dateCreated	2000-11-27
pubmed:abstractText	Increased plasma concentrations of various markers of endothelial damage have been observed in type I diabetic patients, particularly in those with microangiopathy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7608063
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Blood Coagulation Factors, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin, http://linkedlifedata.com/resource/pubmed/chemical/Thrombomodulin, http://linkedlifedata.com/resource/pubmed/chemical/lipoprotein-associated coagulation..., http://linkedlifedata.com/resource/pubmed/chemical/prothrombin fragment 1.2
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0340-6245
pubmed:author	pubmed-author:FontcubertaJJ, pubmed-author:MaterMM, pubmed-author:PérezAA, pubmed-author:RiglaMM, pubmed-author:SoutoJ CJC, pubmed-author:de LeivaAA
pubmed:issnType	Print
pubmed:volume	84
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	223-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10959693-Adolescent, pubmed-meshheading:10959693-Adult, pubmed-meshheading:10959693-Age Factors, pubmed-meshheading:10959693-Aged, pubmed-meshheading:10959693-Analysis of Variance, pubmed-meshheading:10959693-Biological Markers, pubmed-meshheading:10959693-Blood Coagulation Factors, pubmed-meshheading:10959693-Blood Glucose, pubmed-meshheading:10959693-Cholesterol, LDL, pubmed-meshheading:10959693-Diabetes Mellitus, Type 1, pubmed-meshheading:10959693-Endothelium, Vascular, pubmed-meshheading:10959693-Female, pubmed-meshheading:10959693-Fibrinolytic Agents, pubmed-meshheading:10959693-Follow-Up Studies, pubmed-meshheading:10959693-Hemostasis, pubmed-meshheading:10959693-Humans, pubmed-meshheading:10959693-Hyperglycemia, pubmed-meshheading:10959693-Lipids, pubmed-meshheading:10959693-Lipoproteins, pubmed-meshheading:10959693-Male, pubmed-meshheading:10959693-Matched-Pair Analysis, pubmed-meshheading:10959693-Middle Aged, pubmed-meshheading:10959693-Peptide Fragments, pubmed-meshheading:10959693-Prothrombin, pubmed-meshheading:10959693-Thrombomodulin
pubmed:year	2000
pubmed:articleTitle	Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
pubmed:affiliation	Department of Endocrinology and Nutrition, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Spain.
pubmed:publicationType	Journal Article